Opportunity Information: Apply for CDC RFA CE15 150102CONT16
Apply for CDC RFA CE15 150102CONT16
- The HHS-CDC in the health sector is offering a public funding opportunity titled "Prescription Drug Overdose Prevention for States" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.136.
- This funding opportunity was created on Feb 20, 2016 and posted on Feb 20, 2016.
- Applicants must submit their applications by Apr 01, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 50 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The "Prescription Drug Overdose Prevention for States" grant opportunity is a Centers for Disease Control and Prevention (CDC) funding announcement under the U.S. Department of Health and Human Services (HHS). It appears as a continuation opportunity, meaning it is intended to continue support for an existing CDC-supported program rather than launch a brand-new competitive cycle. The funding mechanism is a cooperative agreement, which typically indicates that CDC expects to have substantial involvement in the work beyond simply issuing funds, such as providing ongoing technical assistance, performance monitoring, and collaboration on implementation and evaluation. The activity focus is public health, listed under the Health funding activity category, and it is associated with CFDA number 93.136 (a CDC public health assistance program identifier).
The purpose, as reflected in the title and brief description, is to support state-level efforts to prevent prescription drug overdose. In practical terms, programs under this type of announcement usually center on strengthening state capacity to reduce overdose deaths and misuse tied to prescription opioids and other controlled medications. While the source text provided does not list specific required activities, CDC state overdose prevention cooperative agreements commonly emphasize improving data collection and surveillance (so states can identify high-risk prescribing patterns and hotspots), supporting effective use of Prescription Drug Monitoring Programs (PDMPs), promoting safer prescribing practices through guidelines and health system interventions, and expanding coordination across public health, healthcare, behavioral health, and other partners. The overall intent is to help states implement evidence-based strategies that reduce inappropriate prescribing, identify people at risk earlier, and prevent overdoses.
Administratively, the opportunity is identified as CDC RFA CE15-150102CONT16. The original and current application closing date is April 1, 2016, and it was created and posted on February 20, 2016. The listing shows an expected 50 awards, which strongly suggests the program is designed for broad state participation, often aligning with the number of U.S. states and potentially including certain jurisdictions. The award ceiling is listed as 0, which usually means a specific maximum award amount was not provided in the summarized data and would normally be detailed in the full announcement or tied to a formula, continuation funding levels, or negotiated workplans.
Eligibility is summarized as "Others (see text field entitled Additional Information on Eligibility for clarification)," which implies that eligibility is restricted and defined more precisely in the full notice. In many CDC state-focused cooperative agreements, eligible applicants are typically state health departments or their bona fide agents, and sometimes certain territories or local jurisdictions are included depending on the program structure. Because the abbreviated data here references an external eligibility clarification field, the exact eligible applicant types cannot be confirmed from the excerpt alone, but the program is clearly framed around supporting state-led overdose prevention infrastructure and interventions.
In short, this opportunity is a CDC continuation cooperative agreement intended to keep state overdose prevention work moving forward, with CDC collaboration built into implementation. It targets prescription drug overdose prevention at the state level, anticipates around 50 funded recipients, and was due April 1, 2016, under CFDA 93.136.
Frequently Asked Questions (FAQs)
What is the "Prescription Drug Overdose Prevention for States" grant opportunity?
This is a Centers for Disease Control and Prevention (CDC) funding opportunity under the U.S. Department of Health and Human Services (HHS) focused on supporting state-level efforts to prevent prescription drug overdoses.
Which federal agency is offering this funding?
The funding announcement is offered by the CDC, which is part of HHS.
What is the funding mechanism for this opportunity?
The funding mechanism is a cooperative agreement. This typically means CDC expects to have substantial involvement beyond issuing funds, such as providing technical assistance, collaborating on implementation, and monitoring performance and evaluation.
Is this a new competitive grant or a continuation opportunity?
It is described as a continuation opportunity, intended to continue support for an existing CDC-supported program rather than launch a brand-new competitive cycle.
What is the main purpose of the program?
The purpose is to support state-level efforts to prevent prescription drug overdose, with the overall intent of reducing overdose deaths and misuse linked to prescription opioids and other controlled medications.
What types of activities does this program generally support?
The provided information does not list specific required activities. However, state overdose prevention cooperative agreements commonly emphasize strengthening data collection and surveillance, supporting effective use of Prescription Drug Monitoring Programs (PDMPs), promoting safer prescribing practices (including guidelines and health system interventions), and expanding coordination across public health, healthcare, behavioral health, and other partners.
What is the funding activity category?
The activity focus is public health and it is listed under the Health funding activity category.
What is the CFDA number associated with this opportunity?
The opportunity is associated with CFDA number 93.136.
What is the opportunity or announcement identification number?
The opportunity is identified as CDC RFA CE15-150102CONT16.
When was this opportunity posted?
The opportunity was created and posted on February 20, 2016.
What was the application closing date?
The original and current application closing date was April 1, 2016.
How many awards were expected?
The listing shows an expected 50 awards, suggesting broad state participation and potentially including certain U.S. jurisdictions.
What is the maximum (ceiling) award amount?
The award ceiling is listed as 0 in the summarized data. This usually indicates the specific maximum award amount was not provided in the summary and would normally be detailed in the full announcement or tied to continuation funding levels, a formula, or negotiated workplans.
Who is eligible to apply?
Eligibility is summarized as "Others (see text field entitled Additional Information on Eligibility for clarification)," meaning eligibility is restricted and defined more precisely in the full notice. The excerpt does not confirm exact eligible applicant types, but the program is framed around supporting state-led overdose prevention efforts (often state health departments or their bona fide agents in similar CDC programs).
Does CDC participate in program implementation if awarded?
Because this is a cooperative agreement, CDC typically has substantial involvement such as ongoing technical assistance, collaboration on implementation, and performance monitoring and evaluation.
What is the overall intent of the supported state efforts?
The overall intent is to help states implement evidence-based strategies that reduce inappropriate prescribing, identify people at risk earlier, and prevent overdoses.
Browse more opportunities from the same category: Health
Next opportunity: Bridges to the Doctorate (R25)
Previous opportunity: Transparency and Accountability in Political Finance in Paraguay
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA CE15 150102CONT16
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA CE15 150102CONT16) also looked into and applied for these:
| Funding Opportunity |
|---|
| Bridges to the Doctorate (R25) Apply for PAR 16 109 Funding Number: PAR 16 109 Agency: HHS-NIH11 Category: Health Funding Amount: $300,000 |
| Bridges to the Baccalaureate (R25) Apply for PAR 16 110 Funding Number: PAR 16 110 Agency: HHS-NIH11 Category: Health Funding Amount: $300,000 |
| Biomarkers for the Lewy Body Dementias (U01) Apply for RFA NS 16 022 Funding Number: RFA NS 16 022 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Sustained Strengthening of Public Health Laboratory, Transfusion Services, and Health Care Worker Infection Control Practices for Ebola Virus Disease in Liberia Apply for CDC RFA GH15 163002CONT16 Funding Number: CDC RFA GH15 163002CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| To Strengthen Collaboration between CDC and the National TB Controllers and the National Nurse Coalition Project Apply for CDC RFA PS12 120505CONT16 Funding Number: CDC RFA PS12 120505CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Global Partnerships for Cancer Prevention and Control Apply for CDC RFA DP13 131204CONT16 Funding Number: CDC RFA DP13 131204CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| State-based Public Health Laboratory Biomonitoring Programs Apply for CDC RFA EH14 140203CONT16 Funding Number: CDC RFA EH14 140203CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| International TNM and Capacity Building Apply for CDC RFA DP13 130904CONT16 Funding Number: CDC RFA DP13 130904CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Health Department Demonstration Projects for Comprehensive Prevention, Care, Behavioral Health, and Social Services for Men Who Have Sex with Men of Color Apply for CDC RFA PS15 150902CONT16 Funding Number: CDC RFA PS15 150902CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Standardizing Electronic Laboratory and Biomarker Reporting Apply for CDC RFA DP13 131104CONT16 Funding Number: CDC RFA DP13 131104CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| The Prevention and Control of Unintentional Injury and Violence Prevention Through the World Health Organization Apply for CDC RFA CE16 1601 Funding Number: CDC RFA CE16 1601 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| PPHF16: Heart Disease & Stroke Prevention Program and Diabetes Prevention – State and Local Public Health Actions to Prevent Obesity, Diabetes, and Heart Disease and Stroke – Financed Solely by 2016 Prevention and Public Health Funds Apply for CDC RFA DP14 142203PPHF16 Funding Number: CDC RFA DP14 142203PPHF16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Modeling of Infectious Disease Agent Study Research Projects (R01) Apply for PA 16 107 Funding Number: PA 16 107 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Evidence-Based Falls Prevention Programs in Tribal Communities Financed Solely by 2016 Prevention and Public Health Funds (PPHF-2016) Apply for HHS 2016 ACL AOA FP 0133 Funding Number: HHS 2016 ACL AOA FP 0133 Agency: HHS-ACL Category: Health Funding Amount: $150,000 |
| Enhancing Cancer Registries for Early Case Capture of Pediatric and Young Adult Cancer Cases Apply for CDC RFA DP14 140203CONT16 Funding Number: CDC RFA DP14 140203CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Developmental Behavioral Pediatrics Research Network Apply for HRSA 16 039 Funding Number: HRSA 16 039 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Biomarkers Discovery In Parkinsonism (U01) Apply for PAR 16 112 Funding Number: PAR 16 112 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| National Organizations’ Support for State Oral Health Programs Apply for CDC RFA DP13 131304CONT16 Funding Number: CDC RFA DP13 131304CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Characterization of Circulating Pro- and Anti-Geronic Proteins and Peptides (R01) Apply for RFA AG 17 002 Funding Number: RFA AG 17 002 Agency: HHS-NIH11 Category: Health Funding Amount: $350,000 |
| Maximizing Access to Research Careers Undergraduate - Student Training in Academic Research (MARC U-STAR) (T34) Apply for PAR 16 113 Funding Number: PAR 16 113 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA CE15 150102CONT16", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
